Results 121 to 130 of about 10,998 (173)

Targeting the nuclear export receptor exportin-1 in acute myeloid leukaemia: From biology to clinical translation. [PDF]

Clin Transl Med
Liu Y, Yun X, Ding W, Li S, Liu H.
europepmc   +1 more source

Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. [PDF]

Melanoma Res
Yang K, Wu D.
europepmc   +1 more source

Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. [PDF]

Ann Med
Zhang L, Ying S, Fang F, Li Q, An F, Li J, Sun J, Zheng W, Zhai Z, Zhu Y.   +9 more
europepmc   +1 more source

IGF2BP3 inhibition: another home run for RNA-binding protein targeting in hematological malignancies. [PDF]

Haematologica
Penalva LOF.
europepmc   +1 more source

Targeting CDK11 in Rhabdoid Tumor of the Kidney. [PDF]

Cancers (Basel)
Murakami Y, Lam K, Fukui S, Helmke E, Iczkowski KA, Li Y, Satake N.   +6 more
europepmc   +1 more source

Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancer. [PDF]

Proc Natl Acad Sci U S A
Bergman RE, Keeton CI, Sinha IR, Ling JP, Wang Y, Ha L, Mehta EP, Reed SC, Fox EK, O'Grady TM, Yu Y, Fragkogianni S, Chao C, Davidson BA, Miranda AX, Croessmann S, Zhao S, Liu Q, Shyr Y, Dalton WB, Hurley PJ, Park BH.   +21 more
europepmc   +1 more source

Fbrsl1 is required for cranial neural crest development and reflects a conserved function of the human disease-associated protein. [PDF]

Dis Model Mech
Gerstner S, Berger-Santangelo H, Kastens G, Scholtes T, Wäschenbach S, Pauli S, Borchers A.   +6 more
europepmc   +1 more source

The clinical relevance of sole loss of chromosome Y in myeloid neoplasms. [PDF]

Blood Cancer J
Huber S, Hutter S, Meggendorfer M, Pohlkamp C, Haferlach T, Summerer I.   +5 more
europepmc   +1 more source